Literature DB >> 33690265

Detection of a SARS-CoV-2 variant of concern in South Africa.

Houriiyah Tegally1, Eduan Wilkinson1, Marta Giovanetti2,3, Arash Iranzadeh4, Vagner Fonseca1,3, Jennifer Giandhari1, Deelan Doolabh5, Sureshnee Pillay1, Emmanuel James San1, Nokukhanya Msomi6, Koleka Mlisana7,8, Anne von Gottberg9,10, Sibongile Walaza9,11, Mushal Allam9, Arshad Ismail9, Thabo Mohale9, Allison J Glass10,12, Susan Engelbrecht13, Gert Van Zyl13, Wolfgang Preiser13, Francesco Petruccione14,15, Alex Sigal16,17,18, Diana Hardie19, Gert Marais19, Nei-Yuan Hsiao19, Stephen Korsman19, Mary-Ann Davies20,21, Lynn Tyers5, Innocent Mudau5, Denis York22, Caroline Maslo23, Dominique Goedhals24, Shareef Abrahams25, Oluwakemi Laguda-Akingba25,26, Arghavan Alisoltani-Dehkordi27,28, Adam Godzik28, Constantinos Kurt Wibmer9, Bryan Trevor Sewell29, José Lourenço30, Luiz Carlos Junior Alcantara2,3, Sergei L Kosakovsky Pond31, Steven Weaver31, Darren Martin4,5, Richard J Lessells1,8, Jinal N Bhiman9,10, Carolyn Williamson5,8,19, Tulio de Oliveira32,33,34.   

Abstract

Continued uncontrolled transmission of SARS-CoV-2 in many parts of the world is creating conditions for substantial evolutionary changes to the virus1,2. Here we describe a newly arisen lineage of SARS-CoV-2 (designated 501Y.V2; also known as B.1.351 or 20H) that is defined by eight mutations in the spike protein, including three substitutions (K417N, E484K and N501Y) at residues in its receptor-binding domain that may have functional importance3-5. This lineage was identified in South Africa after the first wave of the epidemic in a severely affected metropolitan area (Nelson Mandela Bay) that is located on the coast of the Eastern Cape province. This lineage spread rapidly, and became dominant in Eastern Cape, Western Cape and KwaZulu-Natal provinces within weeks. Although the full import of the mutations is yet to be determined, the genomic data-which show rapid expansion and displacement of other lineages in several regions-suggest that this lineage is associated with a selection advantage that most plausibly results from increased transmissibility or immune escape6-8.

Entities:  

Mesh:

Substances:

Year:  2021        PMID: 33690265     DOI: 10.1038/s41586-021-03402-9

Source DB:  PubMed          Journal:  Nature        ISSN: 0028-0836            Impact factor:   49.962


  516 in total

1.  BNT162b2 vaccine induces neutralizing antibodies and poly-specific T cells in humans.

Authors:  Ugur Sahin; Alexander Muik; Isabel Vogler; Evelyna Derhovanessian; Lena M Kranz; Mathias Vormehr; Jasmin Quandt; Nicole Bidmon; Alexander Ulges; Alina Baum; Kristen E Pascal; Daniel Maurus; Sebastian Brachtendorf; Verena Lörks; Julian Sikorski; Peter Koch; Rolf Hilker; Dirk Becker; Ann-Kathrin Eller; Jan Grützner; Manuel Tonigold; Carsten Boesler; Corinna Rosenbaum; Ludwig Heesen; Marie-Cristine Kühnle; Asaf Poran; Jesse Z Dong; Ulrich Luxemburger; Alexandra Kemmer-Brück; David Langer; Martin Bexon; Stefanie Bolte; Tania Palanche; Armin Schultz; Sybille Baumann; Azita J Mahiny; Gábor Boros; Jonas Reinholz; Gábor T Szabó; Katalin Karikó; Pei-Yong Shi; Camila Fontes-Garfias; John L Perez; Mark Cutler; David Cooper; Christos A Kyratsous; Philip R Dormitzer; Kathrin U Jansen; Özlem Türeci
Journal:  Nature       Date:  2021-05-27       Impact factor: 49.962

2.  Genomic epidemiology of SARS-CoV-2 in Esteio, Rio Grande do Sul, Brazil.

Authors:  Vinícius Bonetti Franceschi; Gabriel Dickin Caldana; Amanda de Menezes Mayer; Gabriela Bettella Cybis; Carla Andretta Moreira Neves; Patrícia Aline Gröhs Ferrareze; Meriane Demoliner; Paula Rodrigues de Almeida; Juliana Schons Gularte; Alana Witt Hansen; Matheus Nunes Weber; Juliane Deise Fleck; Ricardo Ariel Zimerman; Lívia Kmetzsch; Fernando Rosado Spilki; Claudia Elizabeth Thompson
Journal:  BMC Genomics       Date:  2021-05-20       Impact factor: 3.969

3.  Mutation-Specific SARS-CoV-2 PCR Screen: Rapid and Accurate Detection of Variants of Concern and the Identification of a Newly Emerging Variant with Spike L452R Mutation.

Authors:  Huanyu Wang; Sophonie Jean; Richard Eltringham; John Madison; Pamela Snyder; Huolin Tu; Daniel M Jones; Amy L Leber
Journal:  J Clin Microbiol       Date:  2021-07-19       Impact factor: 5.948

4.  Humoral immune response to circulating SARS-CoV-2 variants elicited by inactivated and RBD-subunit vaccines.

Authors:  Yunlong Cao; Ayijiang Yisimayi; Yali Bai; Weijin Huang; Xiaofeng Li; Zhiying Zhang; Tianjiao Yuan; Ran An; Jing Wang; Tianhe Xiao; Shuo Du; Wenping Ma; Liyang Song; Yongzheng Li; Xiang Li; Weiliang Song; Jiajing Wu; Shuo Liu; Xuemei Li; Yonghong Zhang; Bin Su; Xianghua Guo; Yangyang Wei; Chuanping Gao; Nana Zhang; Yifei Zhang; Yang Dou; Xiaoyu Xu; Rui Shi; Bai Lu; Ronghua Jin; Yingmin Ma; Chengfeng Qin; Youchun Wang; Yingmei Feng; Junyu Xiao; Xiaoliang Sunney Xie
Journal:  Cell Res       Date:  2021-05-21       Impact factor: 25.617

5.  SARS-CoV-2 gene content and COVID-19 mutation impact by comparing 44 Sarbecovirus genomes.

Authors:  Irwin Jungreis; Rachel Sealfon; Manolis Kellis
Journal:  Nat Commun       Date:  2021-05-11       Impact factor: 14.919

6.  Rapid Emergence and Epidemiologic Characteristics of the SARS-CoV-2 B.1.526 Variant - New York City, New York, January 1-April 5, 2021.

Authors:  Corinne N Thompson; Scott Hughes; Stephanie Ngai; Jennifer Baumgartner; Jade C Wang; Emily McGibbon; Katelynn Devinney; Elizabeth Luoma; Daniel Bertolino; Christina Hwang; Kelsey Kepler; Cybill Del Castillo; Melissa Hopkins; Henry Lee; Andrea K DeVito; Jennifer L Rakeman; Anne D Fine
Journal:  MMWR Morb Mortal Wkly Rep       Date:  2021-05-14       Impact factor: 17.586

7.  Nanobody Repertoires for Exposing Vulnerabilities of SARS-CoV-2.

Authors:  Fred D Mast; Peter C Fridy; Natalia E Ketaren; Junjie Wang; Erica Y Jacobs; Jean Paul Olivier; Tanmoy Sanyal; Kelly R Molloy; Fabian Schmidt; Magda Rutkowska; Yiska Weisblum; Lucille M Rich; Elizabeth R Vanderwall; Nicolas Dambrauskas; Vladimir Vigdorovich; Sarah Keegan; Jacob B Jiler; Milana E Stein; Paul Dominic B Olinares; Theodora Hatziioannou; D Noah Sather; Jason S Debley; David Fenyö; Andrej Sali; Paul D Bieniasz; John D Aitchison; Brian T Chait; Michael P Rout
Journal:  bioRxiv       Date:  2021-04-10

8.  Severe Acute Respiratory Syndrome Coronavirus 2: The Emergence of Important Genetic Variants and Testing Options for Clinical Laboratories.

Authors:  Blake W Buchan; Joseph D Yao
Journal:  Clin Microbiol Newsl       Date:  2021-05-21

9.  Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Sequence Characteristics of Coronavirus Disease 2019 (COVID-19) Persistence and Reinfection.

Authors:  Manish C Choudhary; Charles R Crain; Xueting Qiu; William Hanage; Jonathan Z Li
Journal:  Clin Infect Dis       Date:  2022-01-29       Impact factor: 9.079

10.  Functional binding dynamics relevant to the evolution of zoonotic spillovers in endemic and emergent Betacoronavirus strains.

Authors:  Patrick Rynkiewicz; Miranda L Lynch; Feng Cui; André O Hudson; Gregory A Babbitt
Journal:  J Biomol Struct Dyn       Date:  2021-07-21
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.